FDA 483 - Aspen Biopharma Labs Pvt., Ltd. - September 21, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Aspen Biopharma Labs Pvt Ltd in Rangareddy, Hyderabad, India, was cited for significant deficiencies across its API manufacturing operations. The inspection revealed severe data integrity issues, a non-functional Quality Unit, inadequate process validation, and poor facility and equipment maintenance, exacerbated by recent flood damage and ongoing renovations. These findings indicate a pervasive lack of control over critical manufacturing processes and documentation.
ID · 549a2e47-d3c8-431a-a7f8-70a44164ebcc